Sponsor Collaborators Module
The Sponsor Collaborators Module contains information about the sponsors and collaborators involved in the clinical trial. This includes lead sponsor details, responsible party information, investigator information, and collaborator organizations that are supporting or conducting the study.
Sponsor Collaborators Module path is as follows:
Study -> Protocol Section -> Sponsor Collaborators Module -> Collaborators
Sponsor Collaborators Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 12:31 AM
NCT ID:
NCT04485260
Responsible Party Type:
SPONSOR
Study:
NCT04485260
Study Brief:
An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 Combined With Ruxolitinib in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Or Post-Essential Thrombocythemia MF (Post ET-MF) Who Have a Suboptimal Response to Ruxolitinib
Protocol Section:
NCT04485260
Collaborators (If Any):